Argentina vs Mexico: The number of people with susceptibility test result for rifampicin
Argentina
36.41
in 2021
Mexico
35.3
in 2021
Argentina rank
127th
Mexico rank
128th
The number of people with susceptibility test result for rifampicin over time
- Argentina
- Mexico
How they compare
Argentina currently reports 36.41 against 35.3 in Mexico, a difference of 1.11.
Across all 5 years both countries report, Argentina has been ahead every year.
Argentina ranks 127th and Mexico ranks 128th of 146 countries.
Argentina has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Argentina | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 22.37 | 1.27 | 21.1 | Argentina |
| 2020s | 30.62 | 29.51 | 1.11 | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Argentina or Mexico?
- Argentina, at 36.41 against 35.3 in Mexico as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Argentina and Mexico?
- 1.11, with Argentina ahead.
- How many years of comparable data are there for Argentina and Mexico?
- 5 years are reported by both, from 2017 to 2021.
- How do Argentina and Mexico rank globally for the number of people with susceptibility test result for rifampicin?
- Argentina ranks 127th and Mexico ranks 128th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.